Drugs / Sulfamethoxazole/trimethoprim
last change Oct 2021 re-read 9 days ago

Sulfamethoxazole/trimethoprim

Developed for
staphylococcus aureus infection

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT03173053 Comparator Feb 2018 → Oct 2021 movement disorder, staphylococcus aureus infection Radboud University Medical Center Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sulfamethoxazole/trimethoprim ClinicalTrials.gov intervention name — accepted as the source's own label NCT03173053 ↗